Workflow
融资融券
icon
Search documents
中科曙光2月25日获融资买入3.94亿元,融资余额87.91亿元
Xin Lang Cai Jing· 2026-02-26 01:36
Core Viewpoint - Zhongke Shuguang's stock experienced a slight decline of 0.96% on February 25, with a trading volume of 3.082 billion yuan, indicating a stable market presence despite minor fluctuations [1]. Financing Summary - On February 25, Zhongke Shuguang had a financing buy amount of 394 million yuan and a repayment of 359 million yuan, resulting in a net financing purchase of approximately 34.78 million yuan [1]. - The total financing and securities balance reached 8.797 billion yuan, with the financing balance accounting for 6.63% of the circulating market value, which is above the 60th percentile level over the past year, indicating a relatively high financing position [1]. - In terms of securities lending, 19,800 shares were repaid, while 4,400 shares were sold, amounting to approximately 398,700 yuan at the closing price, with a remaining securities lending balance of 609,870 yuan, which is below the 10th percentile level over the past year, indicating a low position [1]. Company Performance - As of January 30, Zhongke Shuguang had 405,900 shareholders, an increase of 1.95%, while the average circulating shares per person decreased by 1.91% to 3,603 shares [2]. - For the period from January to September 2025, Zhongke Shuguang reported a revenue of 8.82 billion yuan, reflecting a year-on-year growth of 9.68%, and a net profit attributable to shareholders of 966 million yuan, which is a 25.55% increase year-on-year [2]. Dividend Information - Since its A-share listing, Zhongke Shuguang has distributed a total of 2.024 billion yuan in dividends, with 1.185 billion yuan distributed over the past three years [3]. Institutional Holdings - As of September 30, 2025, among the top ten circulating shareholders, Huatai-PB CSI 300 ETF held 24.9228 million shares, a decrease of 1.0626 million shares from the previous period [3]. - E Fund CSI 300 ETF increased its holdings to 20.9110 million shares, an increase of 2.1347 million shares, while Huaxia CSI 300 ETF reduced its holdings to 13.4385 million shares, a decrease of 181,100 shares [3]. - Hong Kong Central Clearing Limited has exited the list of the top ten circulating shareholders [3].
伊之密2月25日获融资买入2984.98万元,融资余额4.38亿元
Xin Lang Cai Jing· 2026-02-26 01:36
Group 1 - The core viewpoint of the news is that Yizhiming has shown stable financial performance with a notable increase in revenue and net profit, while also experiencing changes in shareholder structure and financing activities [1][2]. Group 2 - As of February 25, Yizhiming's stock price increased by 0.08%, with a trading volume of 198 million yuan. The financing buy-in amount was 29.84 million yuan, while the financing repayment was 21.96 million yuan, resulting in a net financing buy of 7.89 million yuan. The total financing and securities balance reached 463 million yuan [1]. - The financing balance of Yizhiming is 438 million yuan, accounting for 3.55% of the circulating market value, which is below the 50th percentile level over the past year, indicating a relatively low position [1]. - On the short-selling side, there were no shares repaid or sold on February 25, with a short-selling balance of 2.54 million yuan, which is above the 90th percentile level over the past year, indicating a high position [1]. - For the period from January to September 2025, Yizhiming achieved an operating income of 4.306 billion yuan, representing a year-on-year growth of 17.21%, and a net profit attributable to shareholders of 564 million yuan, with a year-on-year increase of 17.45% [2]. - Since its A-share listing, Yizhiming has distributed a total of 1.192 billion yuan in dividends, with 578 million yuan distributed in the last three years [2]. - As of September 30, 2025, the number of Yizhiming shareholders increased to 30,400, with an average of 14,923 circulating shares per person, a decrease of 0.44% from the previous period [2]. - Hong Kong Central Clearing Limited is the second-largest circulating shareholder, holding 25.55 million shares, an increase of 12.45 million shares from the previous period, while Guotou Securities reduced its holdings by 302,000 shares [2].
石英股份2月25日获融资买入2.44亿元,融资余额10.00亿元
Xin Lang Cai Jing· 2026-02-26 01:36
Group 1 - The core viewpoint of the news is that Quartz Co., Ltd. has shown significant trading activity and financial performance, with a notable increase in financing and a decrease in revenue and profit [1][2][3] Group 2 - On February 25, Quartz Co. saw a stock price increase of 1.89% with a trading volume of 1.987 billion yuan, and a net financing purchase of 60.97 million yuan [1] - As of February 25, the total margin balance for Quartz Co. was 1.008 billion yuan, which is 3.72% of its market capitalization, indicating a high level of financing activity [1] - The company reported a revenue of 753 million yuan for the first nine months of 2025, a year-on-year decrease of 24.46%, and a net profit of 135 million yuan, down 56.81% year-on-year [2] - Cumulatively, Quartz Co. has distributed 3.374 billion yuan in dividends since its A-share listing, with 2.945 billion yuan distributed in the last three years [3] - As of September 30, 2025, the number of shareholders decreased by 13.28% to 55,200, while the average number of circulating shares per person increased by 15.32% to 9,813 shares [2]
良信股份2月25日获融资买入4471.51万元,融资余额3.09亿元
Xin Lang Cai Jing· 2026-02-26 01:36
Group 1 - The core viewpoint of the news is that Liangxin Co., Ltd. has experienced fluctuations in its stock performance and financing activities, indicating a mixed market sentiment towards the company [1][2]. - On February 25, Liangxin's stock price decreased by 0.34%, with a trading volume of 440 million yuan. The net financing buy was negative at 706.35 million yuan, indicating more selling than buying in the financing market [1]. - As of February 25, the total balance of margin trading for Liangxin was 309 million yuan, which represents 2.36% of its circulating market value, indicating a relatively high level of financing compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for Liangxin increased by 21.36% to 39,400, while the average circulating shares per person decreased by 17.60% to 23,245 shares [2]. - For the period from January to September 2025, Liangxin reported a revenue of 3.507 billion yuan, reflecting a year-on-year growth of 12.23%, while the net profit attributable to shareholders decreased by 2.08% to 304 million yuan [2]. - Liangxin has distributed a total of 1.986 billion yuan in dividends since its A-share listing, with 744 million yuan distributed over the past three years [2].
洛阳钼业2月25日获融资买入5.77亿元,融资余额51.31亿元
Xin Lang Cai Jing· 2026-02-26 01:36
Group 1 - On February 25, Luoyang Molybdenum Co., Ltd. saw a stock increase of 2.58% with a trading volume of 6.919 billion yuan. The financing buy-in amount for the day was 577 million yuan, while the financing repayment was 429 million yuan, resulting in a net financing buy-in of 148 million yuan. As of February 25, the total financing and securities lending balance was 5.154 billion yuan [1] - The financing balance of Luoyang Molybdenum on February 25 was 5.131 billion yuan, accounting for 1.25% of the circulating market value. This financing balance is above the 90th percentile level over the past year, indicating a high position [1] - On the same day, the company had a securities lending repayment of 76,200 shares and a securities lending sell-out of 62,100 shares, amounting to 1.4562 million yuan at the closing price. The remaining securities lending volume was 982,300 shares, with a balance of 23.0349 million yuan, also above the 70th percentile level over the past year, indicating a relatively high position [1] Group 2 - Luoyang Molybdenum Co., Ltd. was established on December 22, 1999, and went public on October 9, 2012. The company primarily engages in the mining, selection, deep processing, trading, and research of precious metals such as molybdenum, tungsten, and gold. The main business revenue composition includes refined metal product trading (48.56%), concentrate product trading (38.31%), copper (27.14%), cobalt (6.04%), molybdenum (3.12%), phosphorus (2.23%), niobium (1.88%), tungsten (1.17%), and others (0.11%) [2] - As of September 30, 2025, Luoyang Molybdenum achieved an operating income of 145.485 billion yuan, a year-on-year decrease of 5.99%. The net profit attributable to shareholders was 14.280 billion yuan, reflecting a year-on-year increase of 72.61% [2] - Since its A-share listing, Luoyang Molybdenum has distributed a total of 21.562 billion yuan in dividends, with 10.576 billion yuan distributed over the past three years [3]
葵花药业2月25日获融资买入340.09万元,融资余额1.28亿元
Xin Lang Cai Jing· 2026-02-26 01:36
Core Viewpoint - On February 25, 2025, Kewah Pharmaceutical's stock increased by 0.43%, with a trading volume of 30.14 million yuan. The company experienced a net financing outflow of 680,200 yuan on that day, indicating a low financing balance relative to its market value [1]. Financing Summary - Kewah Pharmaceutical had a financing buy-in of 3.40 million yuan on February 25, with a current financing balance of 128 million yuan, accounting for 1.56% of its circulating market value. This financing balance is below the 10th percentile level over the past year, indicating a low position [1]. - In terms of securities lending, the company repaid 2,500 shares and sold 500 shares on February 25, with a selling amount of 7,045 yuan. The current securities lending balance is 2.18 million yuan, which exceeds the 90th percentile level over the past year, indicating a high position [1]. Financial Performance - As of December 31, 2025, Kewah Pharmaceutical reported a revenue of 1.684 billion yuan for the first nine months, a year-on-year decrease of 43.24%. The net profit attributable to shareholders was -33.54 million yuan, a year-on-year decrease of 105.72% [2]. - Cumulatively, since its A-share listing, Kewah Pharmaceutical has distributed a total of 4.045 billion yuan in dividends, with 1.752 billion yuan distributed over the past three years [3]. Shareholder Structure - As of September 30, 2025, Kewah Pharmaceutical had 48,000 shareholders, a decrease of 2.04% from the previous period. The average circulating shares per person increased by 2.08% to 12,166 shares [2]. - Among the top ten circulating shareholders, E Fund CSI Dividend ETF (515180) is the fifth largest, holding 3.4008 million shares, an increase of 239,600 shares from the previous period. Hong Kong Central Clearing Limited is the seventh largest, holding 2.8412 million shares, a decrease of 128,700 shares [3].
红旗连锁2月25日获融资买入1298.69万元,融资余额3.28亿元
Xin Lang Cai Jing· 2026-02-26 01:36
Group 1 - The core viewpoint of the news highlights the financial performance and trading activities of Hongqi Chain, indicating a decrease in both revenue and net profit for the year 2025 [2] - As of February 25, Hongqi Chain's stock price increased by 0.17%, with a trading volume of 1.52 billion yuan, and a net financing outflow of 15.25 million yuan [1] - The company has a total financing and margin trading balance of 328 million yuan, which accounts for 4.10% of its market capitalization, indicating a relatively high level of financing [1] Group 2 - For the period from January to September 2025, Hongqi Chain reported an operating income of 7.108 billion yuan, a year-on-year decrease of 8.48%, and a net profit attributable to shareholders of 383 million yuan, down 1.89% year-on-year [2] - The number of shareholders increased to 69,700, reflecting a 4.39% rise, while the average circulating shares per person decreased by 4.20% to 16,434 shares [2] - The company has distributed a total of 1.562 billion yuan in dividends since its A-share listing, with 926 million yuan distributed over the past three years [2]
北信源2月25日获融资买入3094.91万元,融资余额6.38亿元
Xin Lang Cai Jing· 2026-02-26 01:34
Core Viewpoint - On February 25, Beixin Source experienced a 2.21% increase in stock price with a trading volume of 353 million yuan, indicating active market interest and potential investor confidence [1]. Financing Summary - On the same day, Beixin Source had a financing buy-in amount of 30.94 million yuan and a financing repayment of 42.37 million yuan, resulting in a net financing outflow of 11.42 million yuan [1]. - As of February 25, the total financing and securities lending balance for Beixin Source was 640 million yuan, with the financing balance at 638 million yuan, accounting for 6.33% of the circulating market value, which is above the 90th percentile level over the past year, indicating a high financing level [1]. - In terms of securities lending, Beixin Source repaid 7,600 shares and sold 11,400 shares on February 25, with a selling amount of 79,200 yuan based on the closing price [1]. - The remaining securities lending volume was 388,400 shares, with a securities lending balance of 2.6994 million yuan, also above the 70th percentile level over the past year, indicating a relatively high level of securities lending [1]. Company Overview - Beixin Source Software Co., Ltd. was established on May 28, 1996, and listed on September 12, 2012. The company specializes in the research, production, sales, and technical services of information security software products, serving key national industries such as government, military, finance, and energy [2]. - The revenue composition of Beixin Source includes software products (51.85%), technical services (22.30%), system integration (16.47%), and others (9.37%) [2]. - As of September 30, the number of shareholders was 95,100, a decrease of 5.05% from the previous period, while the average circulating shares per person increased by 5.32% to 13,422 shares [2]. Financial Performance - For the period from January to September 2025, Beixin Source reported a revenue of 116 million yuan, a significant year-on-year decrease of 69.30%, and a net profit attributable to shareholders of -166 million yuan, representing a year-on-year decrease of 249.84% [2]. - Since its A-share listing, Beixin Source has distributed a total of 117 million yuan in dividends, with no dividends paid in the last three years [3]. Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder of Beixin Source was Hong Kong Central Clearing Limited, holding 15.1173 million shares, an increase of 7.8037 million shares from the previous period [3]. - The fourth-largest circulating shareholder, Southern CSI 1000 ETF, held 13.2571 million shares, a decrease of 109,800 shares from the previous period [3]. - The fifth-largest circulating shareholder, Huaxia CSI 1000 ETF, held 7.8790 million shares, a decrease of 15,800 shares from the previous period [3].
扬杰科技2月25日获融资买入2.11亿元,融资余额11.95亿元
Xin Lang Cai Jing· 2026-02-26 01:33
Core Viewpoint - Yangjie Technology has shown significant financial performance with a notable increase in revenue and net profit, indicating strong growth potential in the semiconductor industry [2]. Group 1: Financial Performance - For the period from January to September 2025, Yangjie Technology achieved operating revenue of 5.348 billion yuan, representing a year-on-year growth of 20.89% [2]. - The net profit attributable to shareholders for the same period was 974 million yuan, reflecting a year-on-year increase of 45.51% [2]. - Cumulatively, since its A-share listing, Yangjie Technology has distributed a total of 1.717 billion yuan in dividends, with 1.18 billion yuan distributed over the past three years [3]. Group 2: Shareholder and Market Activity - As of February 25, 2025, Yangjie Technology's stock price increased by 2.89%, with a trading volume of 1.847 billion yuan [1]. - The company recorded a net financing purchase of 43.93 million yuan on February 25, with a total financing balance of 12.01 billion yuan, which is 2.44% of its market capitalization [1]. - The number of shareholders as of February 2, 2025, was 49,000, with an average of 11,064 circulating shares per person, indicating stable shareholder engagement [2]. Group 3: Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the third-largest circulating shareholder, holding 8.312 million shares, an increase of 390,600 shares from the previous period [3]. - The fourth-largest shareholder, E Fund's ChiNext ETF, held 6.165 million shares, a decrease of 1.0355 million shares [3]. - Other notable changes include the exit of several funds from the top ten circulating shareholders, indicating shifts in institutional investment [3].
麦捷科技2月25日获融资买入8561.83万元,融资余额5.31亿元
Xin Lang Cai Jing· 2026-02-26 01:33
Core Viewpoint - 麦捷科技's stock performance shows a slight increase, with significant trading activity and a low financing balance, indicating potential investment opportunities and a stable financial position [1][2]. Group 1: Financial Performance - As of February 13, 麦捷科技 reported a revenue of 2.903 billion yuan for the period from January to September 2025, representing a year-on-year growth of 21.71% [2]. - The net profit attributable to the parent company for the same period was 245 million yuan, reflecting a year-on-year increase of 1.53% [2]. Group 2: Shareholder and Financing Information - As of February 25, 麦捷科技's financing balance was 531 million yuan, accounting for 4.45% of its market capitalization, which is below the 40th percentile level over the past year, indicating a low financing position [1]. - The number of shareholders decreased to 48,000, while the average circulating shares per person increased by 1.58% to 17,297 shares [2]. - The company has cumulatively distributed 444 million yuan in dividends since its A-share listing, with 292 million yuan distributed in the last three years [3]. Group 3: Institutional Holdings - As of September 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited, which increased its holdings by 627,400 shares to 10.6698 million shares [3]. - South China CSI 1000 ETF reduced its holdings by 56,800 shares to 6.4344 million shares, while Huaxia CSI 1000 ETF decreased its holdings by 9,500 shares to 3.8219 million shares [3].